E-poster No. / 壁報編號

C062

Title / 題目

First Author / 第一作者

Bo-Fang Chen

Institution / 單位

1 Division of Breast Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan 2 Comprehensive Breast Health Center, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan 3 School of Medicine, National Yang-Ming Chiao-Tung University, Taipei, Taiwan

Audio / 音訊檔

Author Group / 作者群

Bo-Fang Chen MD1,2, Yi-Fang Tsai MD, PhD1,2+, Ta-Chung Chao MD, PhD2,3+, Pei-Ju Lien MS2, Yen-Shu Lin MD1,2, Chin-Jung Feng MD4, Yen-Jen Chen MD1,2, Han-Fang Cheng MD1,2, Chun-Yu Liu MD, PhD2,5, , Jiun-I Lai MD, PhD5,6, Ling-Ming Tseng MD1,2,7,** , Chi-Cheng Huang MD, PhD1,2, *

Author Group Institution/ 作者群單位

1 Division of Breast Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan 2 Comprehensive Breast Health Center, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan 3 Division of Cancer Prevention, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan. 4 Division of Plastic and Reconstructive Surgery, Department of Surgery Taipei Veterans General Hospital, Taipei, Taiwan 5 Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan. 6 Center of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan. 7 Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan * Corresponding author + Yi-Fang Tsai and Ta-Chung Chao contributed equally to this work

Category / 主題分類

Clinical Research

Keyword / 關鍵字

CDK4/6 inhibitors, breast cancer, real-world data, treatment outcomes, Taiwanese